HomeNewsBusinessRailways to invest Rs 50 crore in startups annually
Trending Topics

Railways to invest Rs 50 crore in startups annually

As part of the new policy, the government will provide a grant of up to Rs 1.5 crore, to selected startups, on an equal sharing basis with the provision of milestone-wise payment.

June 13, 2022 / 21:45 IST
Story continues below Advertisement
Representative image
Representative image

The Ministry of Railways on June 13 launched the Indian Railway Innovation Policy—‘StartUps for Railways’, with an annual budget of around Rs 40-50 crore, as part of its plans to invest in startups to find solutions to problems the Indian Railways is currently facing.

As part of the new policy, the government will provide a grant of up to Rs 1.5 crore, to selected startups, on an equal sharing basis with the provision of milestone-wise payment.

Story continues below Advertisement

Startups will be selected by the Indian Railways after the national carrier floats a problem statement online for the development of a prototype.

The Indian railways will then test the prototypes developed by different startups and enhanced funding will be provided to scale up deployment on the successful performance of prototypes.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show